Skip to main content
. 2015 Jul 3;3(3):503–518. doi: 10.3390/vaccines3030503

Table 2.

Anti Dengue 2 immunogenicity.

(DIII-S, S)P X 1 (DIII-S, S)P X 2 (DIII-S)N X 2
LNI a PRNT50 b LNI PRNT50 LNI PRNT50
0.64 1:10 1.41 1:160 0.21 1:20
0.81 1.51 0.33
0.64 1.51 0.21
0.51 1.81
1.81
0.51
0.41

Individual LNI titers are presented in the same order as for Table 1. a Neutralizing titer expressed as the logarithmic neutralization index (LNI), where samples coming from MVvac2 and MVvac2(HBsAg)N immune animals (eight samples) set the zero for neutralization of DV2 infectivity (see text); b PRNT50 obtained in pooled serum samples for each experimental group, all of tested pre-immune samples lacked reactivity against DV2, PRNT < 1:10, LNI ~ 0.